Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2026-03-01 @ 8:57 PM
Study NCT ID:
NCT02505334
Status:
COMPLETED
Last Update Posted:
2018-09-05
First Post:
2015-07-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.
Sponsor:
Novo Nordisk A/S
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NN2211-4174
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None